Covetrus (CVET)
Healthcare · Medical - Distribution
1 member of Congress has disclosed 1 trade in Covetrus (CVET) since 2019: 0 buys and 1 sale. The most recent was disclosed on Sep 10, 2019.
- Trades disclosed
- 1
- Members trading
- 1
- Buys / sells
- 0 / 1
- Reported value
- $1K–$15K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at CVET
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
CVET: third_quarter 2026 lobbying report
Educate policymakers about Covetrus's role in the veterinary medicine landscape.
Public: Oct 20, 2026, 12:09 PM EDTOriginal source ↗CVET: second_quarter 2026 lobbying report
Educate policymakers about Covetrus's role in the veterinary medicine landscape.
Public: Jul 20, 2026, 12:06 PM EDTOriginal source ↗
Who traded CVET
- Sen. Susan M. Collins (R-ME)0 buys · 1 sale01Sep 10, 2019
All trades
- Sep 10, 2019$1K–$15K
Sen. Susan M. Collins (R-ME)
$1K–$15K · Traded Aug 15, 2019 · disclosed Sep 10, 2019 · Spouse
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.